Related Experiment Video
Updated: Sep 4, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Relationship between Urinary Norepinephrine, Fibrosis, and Arrhythmias in Chronic Chagas Heart Disease with Preserved
Eduardo Marinho Tassi1, Emília Matos do Nascimento1, Marcelo Abramoff Continentino1
1Instituto do Coração Edson Saad, Faculdade de Medicina, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ - Brasil, Rio de Janeiro, RJ - Brasil.
Insights
In Chronic Chagas Cardiomyopathy (CCC), autonomic nervous system integrity is linked to lower fibrosis and higher ejection fraction, despite traditional risks. Norepinephrine levels correlate with ejection fraction and fibrosis, but not ventricular arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
- Cardiac Imaging
Background:
- Chronic Chagas Cardiomyopathy (CCC) requires identification of arrhythmogenic risk factors, especially in patients without moderate to severe ventricular dysfunction.
- Understanding these factors is crucial for managing sudden cardiac death risk in early-stage CCC.
Purpose of the Study:
- To investigate the correlation between frequent premature ventricular contractions (PVCs), left ventricular ejection fraction (LVEF), myocardial fibrosis extent (via Cardiac Magnetic Resonance - CMR), and urinary norepinephrine (NOREPI) in CCC patients with preserved or mildly reduced LVEF.
- To assess the predictive ability of these variables in early-stage CCC.
Main Methods:
- Prospective study including 59 CCC patients.
- Holter monitoring for PVCs (>30/h), CMR for LVEF and fibrosis quantification, and urinary NOREPI measurement (Muskiet method).
- Correlation coefficient matrix analysis was used to determine relationships between variables (p < 0.05 significance).
Main Results:
- Fibrosis was inversely proportional to LVEF (R=-0.61) and NOREPI (R=-0.68).
- PVCs were inversely proportional to LVEF (R=-0.33) and NOREPI (R=-0.27).
- LVEF showed a direct positive correlation with NOREPI (R=0.83).
Conclusions:
- In CCC patients with preserved/mildly reduced LVEF, autonomic nervous system integrity correlates with less myocardial fibrosis and higher LVEF.
- A significant correlation exists between NOREPI levels, LVEF, and myocardial fibrosis.
- However, PVCs were not found to be correlated with these parameters in this specific patient subgroup.
Background:
In Chronic Chagas Cardiomyopathy (CCC), studies are needed to identify arrhythmogenic risk factors in patients in which moderate to severe ventricular dysfunction is not present.
Objective:
To verify the correlation between frequent ventricular arrhythmias (PVC), left ventricular ejection fraction (LVEF), extension of fibrosis by cardiac magnetic resonance (CMR), and urinary norepinephrine measurement (NOREPI) in CCC with preserved or mildly compromised LVEF.
Methods:
The presence of ventricular extrasystoles > 30/h was analyzed on Holter. At CMR, LVEF and quantification of fibrosis mass were evaluated. The dosage of NOREPI was performed using the Muskiet method. The correlation coefficient matrix was calculated to measure the predictive ability of the variables to predict another variable, with p < 0.05 being considered significant.
Results:
A total of 59 patients were included. The mean age was 57.9 + 10.94 years. PVC was detected in 28 patients. The fibrosis variable was inversely proportional to LVEF (R of -0.61) and NOREPI (R of -0.68). Also, the variable PVC was inversely proportional to LVEF (R of -0.33) and NOREPI (R of -0.27). On the other hand, LVEF was directly proportional to NOREPI (R of 0.83).
Conclusion:
In this sample, in patients with CCC with preserved or slightly reduced LVEF, integrity of the autonomic nervous system is observed in hearts with little fibrosis and higher LVEF despite the presence of traditional risk factors for sudden cardiac death. There is correlation between the levels of NOREPI, LVEF, and myocardial fibrosis, but not with PVC.
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Heart Failure
Heart Failure V: Medical Management
Chronic Kidney Disease IV: Nursing Management
Heart Failure Drugs: Diuretics

